AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01741038
Recruitment Status : Not yet recruiting
First Posted : December 4, 2012
Last Update Posted : August 9, 2016
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.